Thomson L A, Law F C, James K H, Matthew C A, Rushton N
University of Cambridge Orthopaedic Research Unit, Addenbrooke's Hospital, UK.
Biomaterials. 1992;13(12):811-8. doi: 10.1016/0142-9612(92)90173-l.
The biocompatibility of particles of four different commercial polymethylmethacrylate (PMMA) bone cements was evaluated by exposing human synovial fibroblasts and mouse peritoneal macrophages to particles of cement. Cell integrity and inflammatory potential were assessed using enzyme release and microscopical examination. Results suggested the occurrence of cell damage in both cell types and macrophage studies indicated inflammatory potential. The response in vivo was investigated by intra-articular injection of the particles into mouse knee joints. Clinical and histological evaluation was performed over 2-52 wk. Particles of all four cements were well tolerated in the joints.
通过将人类滑膜成纤维细胞和小鼠腹腔巨噬细胞暴露于骨水泥颗粒,评估了四种不同商业聚甲基丙烯酸甲酯(PMMA)骨水泥颗粒的生物相容性。使用酶释放和显微镜检查评估细胞完整性和炎症潜能。结果表明两种细胞类型均出现细胞损伤,巨噬细胞研究表明存在炎症潜能。通过将颗粒关节内注射到小鼠膝关节来研究体内反应。在2 - 52周内进行临床和组织学评估。所有四种骨水泥的颗粒在关节中耐受性良好。